Mayo Clinic 1

Rochester, Minnesota 55905

1 studies enrolling now · 2 studies all time

What they study most

Crohn Disease, Urinary Bladder Neoplasms

Studies at this site

• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder — Completed